ESC 365 - Should we address other lipid/lipoproteins besides LDL-C?

ESC Premium Access

Should we address other lipid/lipoproteins besides LDL-C?

Session: Lipid-lowering therapy: how to tailor treatment to your patient

Topic: Drug therapy

Speaker: Professor R. Frikke-Schmidt (Copenhagen, DK)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Ruth Frikke-Schmidt

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

3 presentations

0 follower

3 more presentations in this session

Treatment intensity in primary and secondary prevention? The role of precision medicine.

Speaker: Professor J. Deanfield (London, GB)

When should we add PCSK-9 inhibitors?

Speaker: Professor S. Nicholls (Melbourne, AU)

Is there a place for anti-inflammatory medication in clinical practice?

Speaker: Professor K. Ray (London, GB)

Access the full session

Lipid-lowering therapy: how to tailor treatment to your patient

Speakers: Professor R. Frikke-Schmidt, Professor J. Deanfield, Professor S. Nicholls, Professor K. Ray

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources